(Q40040623)

English

CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib

scientific article published on 5 December 2007

Statements

CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib (English)
Michael Williams
Gabriella Pezzoni
Cecilia Allievi
Nicoletta Pescalli
Stefano di Giovine
Paola de Feudis
Ivan Strepponi
Riccardo Ferracini
Susan Jones-Bolin
Kathryn Hunter
Alberto Bernareggi
Giorgio Inghirami

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit